The Role of Viral Infections in Atherosclerotic Inflammation

Atherosclerosis has long been understood as a chronic inflammatory condition driven by lipid accumulation, endothelial dysfunction, and immune dysregulation. Emerging evidence, however, points to an underappreciated contributor: viral infections. Several common viruses — including hepatitis B and C, HIV, herpes simplex virus, and cytomegalovirus — may play a significant role in initiating or accelerating atherosclerotic inflammation. Stem Cells as Viral Targets Within atherosclerotic plaques, stem and pluripotent cells form a critical proliferative pool. These cells are particularly susceptible to viral invasion. When infected, stem cells can generate clones that perpetuate dysfunction across successive generations of daughter cells. Even subtle impairment in stem cell function may result in the production of defective mature cells, which then enter the inflammatory microenvironment of the plaque, disrupting immune regulation and accelerating pathological remodeling. Beyond Circulating Cells Viral effects are not limited to circulating stem cells. Active proliferation occurs within the plaque itself — in fibrous cap cells, smooth muscle cells, and vascular endothelium. Each of these populations represents a potential viral target, with infection altering cellular behavior in ways that may promote plaque instability. A Multifactorial Picture The cellular pools found in different atherosclerotic plaques may derive from distinct clonal lineages, each shaped by its specific infectious history. This clonal diversity becomes particularly relevant during plaque remodeling and rupture — events with major clinical consequences. Importantly, no single virus explains the full complexity of atherosclerosis. A specific viral episode may trigger a cascade of pathophysiological events that, over time, become obscured within the broader inflammatory process. This argues against any monocausal viral theory and underscores the multifactorial nature of the disease. Conclusion Viral infections represent one thread in the complex fabric of atherosclerotic inflammation — significant enough to warrant clinical attention, yet insufficient as a standalone explanation. Understanding how specific viruses interact with the proliferative pools of atherosclerotic plaques may open new avenues for both prevention and targeted intervention. You can learn more by reading our e-book or listening to our audiobook